Turn insights into actions with Aktiia’s clinically validated optical blood pressure monitor. We turn insights into action in the fight against hypertension. At Aktiia, we harness the power of data to inform and engage people with hypertension and to enable physicians to deliver more targeted and timely care.
The unique data from Aktiia’s automated 24/7 blood pressure solution leads to never-before-possible insights about cardiovascular health. It’s our mission to transform this data into programs and services that will help people live their lives free from hypertension.
Swiss company Aktiia, whose cuffless blood pressure monitor we’ve been following for several years, announced that their wrist-worn device has received the CE Mark as a Class IIa medical device in Europe, and is now available for pre-order in the UK through the Aktiia website.
Aktiia recently completed a pivotal trial whose preliminary results suggest that the device was able to meet a requirement of less than 5 mmHG mean difference (<8 mmHG standard deviation) between its readings and a reference measurement using double auscultation over a period of one month.
In addition to the device itself, the kit comes with access to a smartphone app and an initialization cuff, meaning it appears you’ll have to calibrate the device at least once. But the release of Aktiia is huge progress in the ability to measure blood pressure without squeezing your limbs, something that has been a long-sought goal of medicine. The device is still awaiting FDA clearance, and we’re eager to have it available here in the U.S.!
We use a standard optical sensor for HR monitoring and we look at what the waves do. Using pulse wave analysis, we can identify fingerprints of the blood pressure, then modulate the signal in a way that we can derive exact blood pressure signals.
Depending on the blood pressure, these waves change. So do the…
Also Read: CUSTOMFLEX® – The ARTIFICIALIRIS For Patients With Aniridia